nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Bacillus calmette-Guérin (BCG): Mechanismof action in superficial bladder cancer
|
Ratliff, Timothy L. |
|
1991 |
37 |
5S |
p. 8-11 4 p. |
artikel |
2 |
BCG treatment of superficial transitionalcell carcinoma
|
Schellhammer, Paul F. |
|
1991 |
37 |
5S |
p. 16-18 3 p. |
artikel |
3 |
Comparison of BCG with other intravesical agents
|
Lamm, Donald L. |
|
1991 |
37 |
5S |
p. 30-32 3 p. |
artikel |
4 |
Increasing incidence, but stable mortality,of bladder cancer in Ontario
|
Jewett, Michael A.S. |
|
1991 |
37 |
5S |
p. 4-7 4 p. |
artikel |
5 |
Indications for BCG use in carcinoma in situ
|
Brosman, Stanley A. |
|
1991 |
37 |
5S |
p. 12-13 2 p. |
artikel |
6 |
Introduction
|
Jewett, Michael A.S. |
|
1991 |
37 |
5S |
p. 3- 1 p. |
artikel |
7 |
Panel discussion
|
|
|
1991 |
37 |
5S |
p. 24-25 2 p. |
artikel |
8 |
Panel discussion
|
|
|
1991 |
37 |
5S |
p. 14-15 2 p. |
artikel |
9 |
Panel discussion
|
|
|
1991 |
37 |
5S |
p. 19-20 2 p. |
artikel |
10 |
Panel discussion
|
|
|
1991 |
37 |
5S |
p. 28-29 2 p. |
artikel |
11 |
Prophylaxis for recurrent transitional cell carcinoma
|
Lamm, Donald L. |
|
1991 |
37 |
5S |
p. 21-23 3 p. |
artikel |
12 |
Techniques for BCG administration
|
Brosman, Stanley A. |
|
1991 |
37 |
5S |
p. 26-27 2 p. |
artikel |